ColciGel®

About Gensco Pharma

Gensco Pharma is a private, commercial-stage biotech company specializing in innovative drug delivery systems, primarily for pain management and related conditions. Its core business revolves around its patented transdermal and topical delivery platforms, which are commercialized through a portfolio of branded prescription products like LidoDose® and ColciGel®. The company is expanding its pipeline through strategic acquisitions, most notably the global rights to RizaFilm® (rizatriptan oral film) for migraine, with a U.S. launch planned for Q4 2025. Gensco operates as a fully integrated company, handling manufacturing, marketing, and distribution, primarily through partnerships with distributors.

Therapeutic Areas

Other Gout Flares Drugs